Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Genmab Q4 2025 Earnings Call - 2026 lined up for multiple registrational readouts that could enable 2027 launches
Genmab closed 2025 with solid top-line growth and rising operating profit while pivoting hard into a late-stage, launch-ready company. Revenue rose 19% to $3.7 billion, proprietary product sales surge...
- 2025 financials: total revenue $3.7 billion, up 19% year-over-year; operating profit $1.26 billion, with operating expenses up 13% to fund strategic investments.
- Proprietary sales momentum: Genmab sold $632 million of its own medicines in 2025, up 54% year-over-year, driven largely by Epkinly and Tivdak.
- Epkinly commercial strength: Epkinly generated $468 million in 2025, a 67% increase, and holds dual approvals in DLBCL and follicular lymphoma across the US, Europe and Japan, now approved in over 65 countries.
- +12 more takeaways
Louisiana-Pacific Corporation Q4 2025 Earnings Call - Strong Siding and ExpertFinish offset OSB price collapse, Q1 downturn ahead
LP closed 2025 with a split personality. Siding delivered resilient top-line growth, margin expansion and standout adoption of ExpertFinish, while OSB suffered a commodity price rout that pushed real ...
- Leadership change: Jason Ringblom succeeded Brad Southern as CEO, emphasizing continuity and strategic focus on market share and product innovation.
- 2025 full-year results: Net sales $2.7 billion, adjusted EBITDA $436 million, adjusted EPS $2.65.
- Siding strength: Full-year siding revenue grew 8%, driven by +4% net selling prices and +4% volumes; siding EBITDA was $444 million, up $54 million year-over-year, with a 26% margin.
- +12 more takeaways
Palatin Technologies Q2 FY2026 Earnings Call - Capital Raise Restores Listing, Funds MC4R Obesity INDs in 2026
Palatin used an $18.2 million upsized public offering to shore up its balance sheet and regain NYSE American compliance, providing the cash runway management says will extend beyond March 31, 2027. Th...
- Completed an upsized underwritten public offering on November 12, 2025, raising $18.2 million gross, $16.9 million net after fees, including full exercise of the over-allotment.
- Issued Series J (exercise $6.50, 18-month or FDA IND trigger) and Series K (exercise $8.125, 5-year) warrants, creating potential incremental funding of up to another $18.2 million if Series J warrants are exercised, but exercise is not assured.
- Public offering restored compliance with NYSE American and resumed trading, though management slipped on the ticker symbol in comments (PTN vs PTM), a small but notable communication inconsistency.
- +11 more takeaways
Otter Tail Corporation Q4 2025 Earnings Call - Rate-base growth funds plan, no external equity needed through 2030
Otter Tail closed 2025 with $6.55 of diluted EPS, down 9% year‑over‑year as plastics earnings receded from 2024 highs. The utility continued to carry the story, delivering double-digit rate‑base growt...
- 2025 diluted EPS was $6.55, down 9% from 2024, but toward the upper end of the prior guidance range.
- Company initiated 2026 EPS guidance of $5.22 to $5.62, midpoint $5.42, implying mid‑teens and above average ROE continuity for the utility.
- Otter Tail Power electric segment earnings rose more than 7% in 2025, driven by increased rate base recovery, higher residential and commercial sales, nearer‑normal weather, and lower O&M.
- +12 more takeaways
USA Compression Partners Fourth Quarter 2025 Earnings Call - J-W Power Deal Upsizes Fleet and Guidance, Raises Lead-Time Questions
USA Compression closed the J-W Power acquisition on January 12 and walked into 2026 with a larger, more geographically diverse fleet, higher 2026 guidance, and a clear plan to squeeze operational syne...
- Company closed J-W Power acquisition on January 12, 2026, expanding geographic reach and horsepower mix across U.S. basins.
- 2025 was a record year: Adjusted EBITDA of $613.8 million and Distributable Cash Flow of $385.7 million.
- Management provided 2026 guidance including Adjusted EBITDA of $770 million to $800 million and DCF of $480 million to $510 million, inclusive of JW contribution.
- +15 more takeaways
SunCoke Energy Q4 2025 Earnings Call - Phoenix drives industrial rebound while Algoma breach and Haverhill One closure weigh on results
SunCoke closed 2025 with a messy but manageable scorecard. Consolidated adjusted EBITDA was $219.2 million for the year and $56.7 million in Q4, results dinged by a shift from spot to contract coke sa...
- Consolidated adjusted EBITDA for 2025 was $219.2 million; Q4 adjusted EBITDA was $56.7 million, down year over year.
- Company reported a Q4 net loss attributable to SunCoke of $1.00 per share, driven by one-time items totaling about $0.85 per share net of tax; full year net loss was $0.52 per share, with one-time items of $0.97 per share.
- Phoenix Global acquisition materially reshapes the industrial services segment; SunCoke paid a net purchase consideration of $295.8 million and acquired $24.3 million cash on closing.
- +13 more takeaways
HIVE Digital Technologies Q3 2026 Earnings Call - Record revenue, 25 EH scale and a fast pivot into GPU/HPC with $35M ARR milestone
HIVE reported a record quarter for the period ended December 31, 2025, driven by rapid mining scale in Paraguay and a deliberate, CapEx-light push into GPU cloud and HPC. Revenue reached $93.1 million...
- Record quarterly revenue of $93.1 million for the period ended December 31, 2025, with adjusted EBITDA of $5.7 million.
- HIVE installed capacity reached 25 exahash and operated an average of 22.8 exahash during the quarter, producing ~880 Bitcoin equivalent in the period.
- Ending Bitcoin treasury reported at 481 BTC, with additional pledged positions providing downside protection at an $87,000 strike for certain lots.
- +11 more takeaways
Watsco Q4 2025 Earnings Call - A2L transition largely behind us; margins up and dividend hiked 10%
Watsco closed 2025 claiming the worst of the A2L and R-410A shakeout is over, and management is leaning into margin expansion, tech investment, and M&A while returning cash to shareholders. The compan...
- Management says the A2L product transition and related regulatory noise are largely behind the company, presenting a simpler operating year for 2026.
- Watsco raised its annual dividend 10% to $13.20, marking the 52nd consecutive year of dividends and reflecting confidence in cash flow.
- Q4 gross margin widened 40 basis points to 27.1%, and management reiterated a long-term ambition north of 30% gross margin.
- +12 more takeaways
Itron Q4 2025 Earnings Call - Record profitability and ARR surge, resiliency acquisitions lift margins but shave 2026 EPS
Itron closed out 2025 with record margins, earnings, and cash flow while reshaping its business toward recurring revenue and resiliency software. Q4 delivered $572 million of revenue, $99 million of a...
- Q4 results beat expectations: revenue $572 million, adjusted EBITDA $99 million, non-GAAP EPS $2.46, and free cash flow $112 million.
- Bookings in Q4 were $737 million, leaving a total company backlog of $4.5 billion and an Outcomes backlog above $1 billion.
- Itron ended Q4 with $368 million of ARR, up about 20% year over year; management expects ARR growth in 2026 of mid-teens to up to 20% (including the acquisitions).
- +11 more takeaways
Sunoco LP Q4 2025 Earnings Call - Parkland acquisition fuels record EBITDA and commits to 5%+ distribution growth
Sunoco closed the Parkland deal on October 31 and finished Q4 and FY 2025 with record cash flow and a materially larger footprint. Excluding roughly $60 million of one-time transaction costs, Q4 adjus...
- Parkland closed Oct 31; integration is underway and progressing well, materially expanding Sunoco’s footprint to 32 countries and territories.
- Q4 adjusted EBITDA was $706 million, excluding approximately $60 million of one-time transaction expenses.
- Full-year 2025 adjusted EBITDA was a record $2.12 billion, up 36% year over year, reflecting legacy growth plus Parkland contribution.
- +12 more takeaways